Member Info for xviolet

hmmmm

https://www.biorxiv.org/content/10.1101/2022.01.20.476754v1

any thoughts? I think the first part of this pre-print reads well for Synairgen and interferon therapy with omicron.

Remember you can report a post/poster if they are offensive or unethical.
And sometimes LSE remove the poster and posts. And block them.
I think the more reports the more likely it is a troll is removed.

ThinShins

I've been reading that pre-print.

redundant.
but...50 mutations....
its not the same virus. is it?

Thanks Doc. However they could get great results for Delta (and positive EUA-friendly Sprinter) and fail to touch Omicron. That make might it difficult to estimate the sp.

BOJO

Thank you for the reply. Lets hope its a positive outcome.

For SYN's sake I didn't like the fact the researchers struggled with the amount of 'exogenously added IFNs' to suppress the virus. I guess...we shall see

anyone bought/sold brii?
sp a bit low atm?

Brii going for EUA
sp not exactly wild
and they got positive in vitro for omicron

So we should get those results soon. Then.
Thank you.

I think we were trolled even before the RNS - quite a few messages saying '3p' etc. Then it re-rates and its '8p...'

Just filter them. No idea where they come from but its obvious this has an upwards trajectory, that's why they want to buy cheap. Its been interesting to see all the smarter, more technical posters come out over the weekend - plenty of upside here.

Press release Dec 8th...

"Synairgen is investigating the in vitro activity of SNG001 against the Delta and Omicron variants of SARS-CoV-2 and will make data available as soon as possible."

How long does it take to do In Vitro? Anyone know?

Are we still waiting?
Sorry if I missed an update. But are we still waiting ?

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
https://www.biorxiv.org/content/10.1101/2022.01.20.476754v1

This isn't peer reviewed - but it may suggest Syn potentially less efficacious against Omicron and therefore, presumably the Omicron 'family' of variants - the degree of reduced efficacy? I have no idea. Maybe no one has. Syn's P3 and Activ is obviously not tested/trailled on Omicron strains. It is fascinating and terrible this Covid business - by the time a therapeutic is developed the virus it was tested and trailed on may no longer exist, in a meaningful sense. Or it could be getting ready to re-circulate in a new form. A lot to think about.

The filter button is your friend

There was some huge buys this week. And, I think, at exactly the same time a troll - who, I half-believe, had a profile that was purpose designed to create maximum emotional disturbance - based on the profile of the average LSE BB user. If so - that is a new low.

But I have seen it on other comps - there's a huge buy in the b/g and trolls come out in the foreground. The relation between these phenomena, I guess is debate-able.

That was a mad day. Have added one more person to my filter list - sorry I don't like people who get 2 gleeful about share prices dropping - not my style at the moment. And added a few in the 11s and 12s. I have no idea where this one is going so nothing more to say! Good weekend all.

Dai

Sorry you ended up with a sexual predator - the other Michael has some very interesting things to say. I can't remember which are the best interviews but if I have time I'll share the link - but it was one of the youtube interviews. I watched a few and thought he was good. Followed him into Radisson Mining (which I need to buy back again as a long).

Like the theory Porky.
Also if I wanted to design an avatar to come on here and wind people up - to knock down the price, while I buy, I wonder what kind of character I would create....bearing in mind what kind of people, we imagine, are reading this etc

fraying.

I filtered someone a while ago but he seems to be getting everyone hot under the collar.
I kind of think anywhere between 10-13p is OK for this share in the short to medium term.
Beyond that upside so significant that any fluctuations will pale into insignificance.
You could hang on for a lower price. Or even a placing. Or you could miss a good entry point today.
Ho-hum...its always hard to decide!